Index. Note: Page numbers of article titles are in boldface type.

Transcription

1 Index Note: Page numbers of article titles are in boldface type. A ABCDE acronym, for melanoma, Acanthosis nigricans, malignant, 430 Acetretin, for psoriasis, 363 Acquired perforating dermatosis of end-stage renal disease, 426 Acral erythema, chemotherapy-induced, 403 Acral lentiginous melanoma, 410, Acral nevi, Acrodermatitis/acrokeratosis paraneoplastica, 430 Adalimumab adverse reactions to, 405 for psoriasis, Adapalene, for plantar warts, 346 Adverse drug reactions, to systemic agents, to topical medications, Aerosols, for drug delivery, Allergic contact dermatitis, Allopurinol, for Kyrie disease, 426 Alternative therapies, for plantar hyperhidrosis, 449 Aluminum chloride, for plantar hyperhidrosis, Amelanotic melanoma, 410 Amorolfine, for onychomycosis, 312 Anesthesia, 325 Animal bites, 370 Ant stings, 370 Anticoagulants, adverse reactions to, 402 Antihistamines, for insect bites, 370 Antiperspirants, for plantar hyperhidrosis, Anxiety, in plantar hyperhidrosis, 444 Apremilast, for psoriasis, 363 Arteriopathy, calcific uremic, Arthritis, psoriatic, Ash leaf macules, 431 Athlete s foot, 375 Atopic dermatitis, 377 Atypical nevi, Auspitz sign, 380 Avoidance, for dermatitis, 379 Clin Podiatr Med Surg 33 (2016) /16/$ see front matter podiatric.theclinics.com

2 454 Index B Bacterial endocarditis, subacute, 428 Bazex syndrome, 430 Beau lines, 436 Bee stings, 370 Bevacizumab, adverse reactions to, 403 Biologic agents, for psoriasis, 363 Biopsy for melanoma, for nail disorders, 320, for onychomycosis, 307 for pediatric patients, Bites, animal, insect and human, 370 Bleomycin, for plantar warts, Blisters from heat and cold, 369 in bullous diabeticorum, 424 Bloodless field, for nail surgery, Blue nevi, Botulinum toxin, for plantar hyperhidrosis, BRAF mutations, in melanoma, 419 Bruising, 371 Bullosis diabeticorum, 424 Burns, Butcher s warts, 341 C Café au lait spots, 431 Calcaneal petachiae, 371 Calciphylaxis, Cancer, cutaneous markers of, Candida albicans immunotherapy with, for plantar warts, 348 in infections, 376 Cantharidin, for plantar warts, 347 Carbuncles, 352 Cardiovascular disorders, cutaneous markers of, Cellulitis, 352 Chemicals burns due to, 369 contact dermatitis due to, Chemotherapy, adverse reactions to, 401, , 434 Chickenpox, Child abuse, 371 Chloroquine, pigmentation due to, 401 Ciclopirox, for onychomycosis, 310, 389 Cimetidine, for plantar warts, 347 Clubbing, digital, 436 Cold injuries,

3 Index 455 Collodion baby, 430 Common warts, 340 Congenital melanocytic nevi, Contact dermatitis, , Corticosteroids for psoriasis, 362 for pyoderma gangrenosum, fungal infections due to, Coxsackievirus infections, 374 Creams for dermatitis, 379 for drug delivery, Crohn disease, Cryotherapy, for plantar warts, 346 CUBED acronym, for melanoma, 413 Culture, for onychomycosis, 307 Cyclosporine for psoriasis, 363 for pyoderma gangrenosum, D Dabrafenib, adverse reactions to, 404 Dactylitis, psoriatic, 361 Debrafenib, for melanoma, 419 Debridement for onychomycosis, 310 for plantar warts, 345 Depot effect, of topical formulations, 392 Depression, in plantar hyperhidrosis, 444 Dermatitis, Dermatologic manifestations adverse drug reactions as, human papillomavirus infections, in pediatric patients, in systemic disease, melanoma. See Melanoma. nail surgery for, onychomycosis. See Onychomycosis. plantar hyperhidrosis, psoriasis, topical treatment of, Dermatophytosis, , Dermopathy, diabetic, Dermoscopy, for melanoma, 413, 417 Diabetes mellitus cutaneous markers of, onychomycosis recurrence in, 312 Digital clubbing, 436 Docetaxel, adverse reactions to, 404 Dosage form, for topical agents,

4 456 Index Duct tape, for plantar warts, 347 Dyshydrotic eczema, 378 E Econazole, formulations for, 391 Eczema, Edema, in drug reactions, 400 Efinaconazole, for onychomycosis, , , 389 Electrical burns, 370 Emotional stress, in plantar hyperhidrosis, 444 En bloc excision, Endocrine pathology, plantar hyperhidrosis in, 442 Endophytic warts, Enthesitis, psoriatic, Environmental factors, in skin disorders, Epidermis, drug application and metabolism in, Epidermolytic palmoplantar hyperkeratosis, Epinephrine, for insect bites, 370 Eruptive xanthomas, diabetic, 425 Erythasma, pitted, 373 Erythema(s) chemotherapy-induced, 403 cutaneous markers of, Erythema annulare centrifugum (erythema perstans), Erythema multiforme, 432 Erythema nodosum, 400, Erythrodermic psoriasis, 357 Erythronychia, longitudinal, , 324, Etanercept adverse reactions to, 405 for psoriasis, 363 Exanthems, viral, Excipients, in topical formulations, Excision, for plantar warts, 350 F Fibromas, Fibrosing dermopathy, nephrogenic, 426 Fifth disease, 373 Filiform warts, 340, 342 Fixed drug eruptions, Flat warts, 343 Flexural (inverse) psoriasis, Fluorouracil adverse reactions to, 402 for plantar warts, Foams, for drug delivery, Folk remedies, for plantar warts, 345 Folliculitis, 352

5 Index 457 Footwear as onychomycosis reservoir, 313 for plantar hyperhidrosis, 449 injuries from, 371 Fragrances, in topical formulations, 388 Frostbite, Frostnip, 369 Fungal infections, onychomycosis, treatment of, topical drug vehicles for, G Gadolinium-based contrast agents, dermopathy from, Gels, for drug delivery, Gemcitabine, adverse reactions to, 403 Genetic disorders and factors cutaneous markers of, 431 genodermatoses, primary hyperhidrosis, 444 psoriasis, 356 Genital warts, 344 Glucagonoma syndrome, 430 Glycopyrrolate, for plantar hyperhidrosis, Granulomas, pyogenic, chemotherapy-induced, 405 Graves disease, 429 Guttate psoriasis, 356, H Hamartomas, 431 Hand-foot-and-mouth disease, 374, 403 Heat injuries, Henoch-Schönlein purpura, Heparin, adverse reactions to, 402 Hereditary dermatoses, Herpes simplex infections, 374 Herpes zoster, 374 Hot foot syndrome, 373 HPV (human papillomavirus) infections. See Plantar warts. Human bites, 370 Human papillomavirus infections. See Plantar warts. Hydration, topical formulations for, 387 Hydrogel formulations, 389 Hydroxychloroquine, pigmentation due to, 401 Hypercoagulability, 431 Hyperhidrosis, plantar, Hyperhidrosis Disease Severity Scale, Hyperkeratosis hereditary, 371 in plantar warts, 338

6 458 Index Hyperkeratosis (continued) inherited, Hyperpigmentation, in drug reactions, Hyperthyroidism, 429 I Ichthyosis, 430 Imatinib adverse reactions to, 403 pigmentation due to, 401 Immunosuppressive agents, adverse reactions to, 405 Immunotherapy, for plantar warts, 348 Impetigo, 352 Incontinentia pigmenti, 323 Infections in dermatitis, 379 in pediatric patients, 372 Inflammation, in dermatitis, Inflammatory bowel disease, Infliximab adverse reactions to, 405 for psoriasis, for pyoderma gangrenosum, Ingrown nails, 382 Injuries, Insect bites and stings, 370 Intertriginous (inverse) psoriasis, 357 Inverse psoriasis, 357 Iontophoresis, for plantar hyperhidrosis, Ipilimumab, for melanoma, Irritant contact dermatitis, J Jackson-Lawler type of pachyonychia congenita, Jadassohn-Lewandowsky type of pachyonychia congenita, Janeway lesions, 428 Juvenile plantar dermatitis, K Keratoderma(s), palmoplantar, 430 Keratoderma blennorrhagicum, 434 Keratolysis, pitted, 373 Keratolytics, 372 Keratosis palmoplantaris mutilans, Kidney disease, cutaneous markers of, Koebner phenomenon, 345, 356, 380 Koilonychia, 436 Kyrie disease (acquired perforating dermatosis of end-stage renal disease), 426

7 Index 459 L Lacquer-based therapy, for onychomycosis, 308, Lactic acid, for hyperkeratosis, 372 Laser therapy for onychomycosis, 310 for plantar hyperhidrosis, for plantar warts, Lateral longitudinal excision biopsy, 327, 331 Lentigo maligna melanoma, 410 Lidocaine, 325 Longitudinal erythronychia, , 324, Longitudinal melanonychia, 320, 324, 327, , 382 Lotions, for drug delivery, Luliconazole, 392 Lumbar sympathectomy, for plantar hyperhidrosis, 449 M Malignancy, cutaneous markers of, Malignant acanthosis nigricans, 430 Marigold therapy, for plantar warts, Measles, 373 Melanocytic nevi, Melanoma, causes of, clinical presentation of, dermoscopy for, 417 diagnosis of, in pediatric patients, incidence of, metastasis from, of nail unit, 410, prognosis for, staging of, surgery for, 320, treatment of, types of, Melanonychia, longitudinal, 320, 324, 327, , 382 Metastasis, from melanoma, Methotrexate adverse reactions to, 405 for psoriasis, 363 Microspheres, in topical formulations, 388 Minocycline, pigmentation due to, miradry laser, for plantar hyperhidrosis, Mite infestations, 370 Molluscum contagiosum, 374 Monoclonal gammopathy, Mosaic warts, 340, 342 Myrmecia warts, 340

8 460 Index N Nail avulsion, for onychomycosis, Nail disorders in drug reactions, 399, in pediatric patients, 382 in systemic disease, melanoma, 410, onychomycosis. See Onychomycosis. psoriasis, Nail surgery, complications of, 333 evaluation for, indications for, techniques for, Necrobiosis lipoidica diabeticorum, Necrosis, anticoagulant-induced, 402 Nephrogenic fibrosing dermopathy, Neurofibromatosis, 431 Nevi, Nodular melanoma, 410 NRAS mutations, in melanoma, 419 O Ointments, for drug delivery, Onychodystrophy, psoriatic, Onychomadesis, chemotherapy-induced, 404 Onychomycosis, classification of, 306 differential diagnosis of, 307 drug formulations for, 389 evaluation of, in pediatric patients, 376, 382 incidence of, long-term outcome of, 313 pathogens causing, plantar hyperhidrosis with, 444 recurrence of, risk factors for, treatment of, Osler nodes, 428 Oxybutynin, for plantar hyperhidrosis, P Pachyonychia congenita, Pacitaxel, adverse reactions to, 404 Pain management, for pediatric patients, 368 Palmoplantar erythema, 434 Palmoplantar erythrodysesthesia syndrome, 403

9 Palmoplantar keratodermas, 430 Panniculitis, 400 Paraneoplastic syndromes, Paronychia, 382 Parvovirus B19 infections, 373 Pastes, for drug delivery, Patches drug adverse reactions to, 398 for drug delivery, Pediatric patients, dermatologic concerns in, bacterial infections, dermatitis, diagnosis of, eczema, environmentally induced, fungal infections, inherited, nail disorders, 382 nevi, psoriasis, viral infections, Pembrolizumab, for melanoma, Penetration-enhancing agents, for topical formulations, 387 Permethrin, for scabies, 370 Pernio, 369 Photodamage, 369 Photo-onycholysis, drug-induced, Phototherapy, for psoriasis, 363 Phytotherapy, for plantar warts, Pigmentation, abnormal. See Hyperpigmentation. Pitted keratolysis, 373, Plantar dermatitis, juvenile, Plantar hyperhidrosis, causes of, complications of, criteria for, evaluation of, incidence of, primary, secondary, symptoms of, treatment of, Plantar warts clinical manifestations of, definition of, 338 evaluation of, hyperhidrosis with, 445 in pediatric patients, life cycle of, 344 pathophysiology of, 340 treatment of, Index 461

10 462 Index Plantar (continued) virology of, Plaque psoriasis, 356, Polymerase chain reaction, for onychomycosis, 307 Pompholyx, 378 Potassium hydroxide test, for onychomycosis, 307 Powders, for drug delivery, Proderm, 391 Propylene glycol, for topical formulations, 387 Pseudomonas hot foot syndrome, 373 Psoriasis, clinical presentations of, comorbidities of, diagnosis of, 380 genetics of, 356 in pediatric patients, incidence of, 355 pathogenesis of, 356 treatment of, , Punch biopsy, Pustular psoriasis, , Pyoderma gangrenosum, Pyogenic granulomas, chemotherapy-induced, 405 Q Quinacrine, pigmentation due to, 401 R Rashes, viral, Raynaud phenomenon, 428 Reactive arthritis, 434 Retinoids adverse reactions to, for plantar warts, 346 for psoriasis, 363 Rewarming, for cold injuries, Ringworm, Rituximab, adverse reactions to, 405 Ropivacaine, 325 Rough nails, 382 Rubella, 373 S Salicylic acid for hyperkeratosis, 372 for plantar warts, 346 Scabies, 370 Scalding burns, 369

11 Index 463 Scrub, for surgery, 323, 325 Secondary formulations, 388 Secukinumab, for psoriasis, Sentinel node biopsy, for melanoma, Shagreen patches, 431 Shave biopsy, 327, Shingles, 374 Sirolimus, adverse reactions to, 405 Solutions, for drug delivery, Sorafenib, adverse reactions to, 403 Spitz nevi, Spoon nails (koilonychia), 436 Squamous cell carcinoma, surgery for, 321, 330 Staphylococcal infections, 352 Stasis dermatitis, Stings, 370 Streptococcal infections, 352 Subacute bacterial endocarditis, 428 Sun exposure, 369, Sunitinib, adverse reactions to, 403 Superficial spreading melanoma, 410 Superficial white onychoomycosis, 376 Surgery, nail, Suspensions, for drug delivery, Sweating, excessive, Sweaty sock dermatitis, Sympathectomy, lumbar, for plantar hyperhidrosis, 449 Systemic disease, cutaneous markers of, cardiovascular disorders, diabetes mellitus, erythemas, genetic disorders, 431 keratoderma blennorrhagicum, 434 malignancy, nail manifestations, pyoderma gangrenosum, renal disease, thyroid conditions, 429 vitiligo, T Talon noir, 371 Tanning, 369 Tavaborole, for onychomycosis, , , 389 Taxanes, adverse reactions to, Tazarotene, for psoriasis, 362 Tendinous xanthomas, 425 Terbinafine, for onychomycosis, 312 Terry nails, 438 Thermolysis, for plantar hyperhidrosis,

12 464 Index Thuja occidentalis, for plantar warts, Thyroid conditions, cutaneous markers of, 429 Tinea capitis, 375 Tinea incognito, Tinea pedis, 308, 375 Tinea unguium. See Onychomycosis. Topical agents efficacy of, for onychomycosis, for plantar warts, 346 for psoriasis, 362 generic versus branded, patient preferences for, vehicles for, Tourniquet, for nail surgery, Trachyonychia, 382 Transdermal water loss, 388 Trauma, Trousseau syndrome, 431 Tuberous sclerosis, , 431 Twenty-nail dystrophy, 382 U Ulcerative colitis, Ultraviolet radiation, damage from, 369 Uremic arteriopathy, calcific, Ustekinumab, for psoriasis, V Vaccine, HPV, for plantar warts, 349 Varicella zoster virus infections, Vasculopathy, calcific, Vehicles, for topical agents, barriers to, design of, dosage form and, in secondary formulations, 388 selection of, Vemurafenib adverse reactions to, 404 for melanoma, 419 Verruca pedis. See Plantar warts. Viral warts. See Plantar warts. Vitamin D analogs, for psoriasis, 362 Vitiligo, Vohwinkel palmoplantar hyperkeratosis, Vörner-Unna-Thost type hyperkeratosis, 371

13 Index 465 W Warfarin, adverse reactions to, 402 Warts, plantar. See Plantar warts. Wasp stings, 370 Werner syndrome, 431 Whitlow, herpetic, 374 X Xanthomas, diabetic eruptive, 425 Y Yellow nail syndrome, 436 Z Zalas classification, of onychomycosis, 306